These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30315658)

  • 41. Simultaneous quantitative analysis of uremic toxins by LC-MS/MS with a reversed-phase/cation-exchange/anion-exchange tri-modal mixed-mode column.
    Kanemitsu Y; Asaji K; Matsumoto Y; Tsukamoto H; Saigusa D; Mukawa C; Tachikawa T; Abe T; Tomioka Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():1-8. PubMed ID: 29024911
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mass spectrometry detection in comprehensive liquid chromatography: basic concepts, instrumental aspects, applications and trends.
    Donato P; Cacciola F; Tranchida PQ; Dugo P; Mondello L
    Mass Spectrom Rev; 2012; 31(5):523-59. PubMed ID: 22383300
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitative analysis of pasireotide (SOM230), a cyclic peptide, in monkey plasma using liquid chromatography in combination with tandem mass spectrometry.
    Fu Y; Li W; Flarakos J; Tse FLS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1008():242-249. PubMed ID: 26680325
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Esterase inhibitors as ester-containing drug stabilizers and their hydrolytic products: potential contributors to the matrix effects on bioanalysis by liquid chromatography/tandem mass spectrometry.
    Zheng N; Fung EN; Buzescu A; Arnold ME; Zeng J
    Rapid Commun Mass Spectrom; 2012 Jun; 26(11):1291-304. PubMed ID: 22555922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improved method robustness and ruggedness in liquid chromatography-mass spectrometry by increasing the acid content of the mobile phase.
    Kaufmann A; Butcher P; Maden K; Walker S; Widmer M; Kaempf R
    J Chromatogr A; 2024 Feb; 1717():464694. PubMed ID: 38306921
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulated LC-MS/MS bioanalysis technology for therapeutic antibodies and Fc-fusion proteins using structure-indicated approach.
    Iwamoto N; Shimada T
    Drug Metab Pharmacokinet; 2019 Feb; 34(1):19-24. PubMed ID: 30392772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantitative determination of fifteen basic pharmaceuticals in ante- and post-mortem whole blood by high pH mobile phase reversed phase ultra high performance liquid chromatography-tandem mass spectrometry.
    Amundsen I; Oiestad ÅM; Ekeberg D; Kristoffersen L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():112-23. PubMed ID: 23380540
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IQ consortium perspective: complementary LBA and LC-MS in protein therapeutics bioanalysis and biotransformation assessment.
    Kaur S; Bateman KP; Glick J; Jairaj M; F Kellie J; Sydor J; Zeng J
    Bioanalysis; 2020 Feb; 12(4):257-270. PubMed ID: 32096432
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hydrophilic interaction liquid chromatography-tandem mass spectrometry for quantitation of paralytic shellfish toxins: validation and application to reference materials.
    Thomas KM; Beach DG; Reeves KL; Gibbs RS; Kerrin ES; McCarron P; Quilliam MA
    Anal Bioanal Chem; 2017 Sep; 409(24):5675-5687. PubMed ID: 28730312
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analyses of benzodiazepines and their metabolites in various biological matrices by LC-MS(/MS).
    Nakamura M
    Biomed Chromatogr; 2011 Dec; 25(12):1283-307. PubMed ID: 21400551
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multidimensional approaches in LC and MS for phospholipid bioanalysis.
    Guo X; Lankmayr E
    Bioanalysis; 2010 Jun; 2(6):1109-23. PubMed ID: 21083211
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current advances and strategies towards fully automated sample preparation for regulated LC-MS/MS bioanalysis.
    Zheng N; Jiang H; Zeng J
    Bioanalysis; 2014 Sep; 6(18):2441-59. PubMed ID: 25384595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-regulated LC-MS/MS bioanalysis in support of early drug development: a Novartis perspective.
    Fu Y; Li W; Picard F
    Bioanalysis; 2023 Feb; 15(3):109-125. PubMed ID: 36976931
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bioanalysis of an oligonucleotide and its metabolites by liquid chromatography-tandem mass spectrometry.
    Deng P; Chen X; Zhang G; Zhong D
    J Pharm Biomed Anal; 2010 Aug; 52(4):571-9. PubMed ID: 20153130
    [TBL] [Abstract][Full Text] [Related]  

  • 55. γ-Hydroxybutyrate analysis in human serum with liquid chromatography-tandem mass spectrometry on the basis of MS3 mass transition.
    Dziadosz M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 986-987():8-11. PubMed ID: 25703946
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fluoroalcohols as novel buffer components for basic buffer solutions for liquid chromatography electrospray ionization mass spectrometry: retention mechanisms.
    Kipper K; Herodes K; Leito I
    J Chromatogr A; 2011 Nov; 1218(45):8175-80. PubMed ID: 21968346
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Utilization of hydrophilic-interaction LC to minimize matrix effects caused by phospholipids.
    Tan B; Negahban A; McDonald T; Zhang Y; Holliman C
    Bioanalysis; 2012 Aug; 4(16):2049-58. PubMed ID: 22946920
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation.
    Moreno-Vicente R; Fernández-Nieva Z; Navarro A; Gascón-Crespí I; Farré-Albaladejo M; Igartua M; Hernández RM; Pedraz JL
    J Pharm Biomed Anal; 2015 Oct; 114():105-12. PubMed ID: 26037158
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liquid chromatography tandem-mass spectrometry (LC-MS/MS)--technique and applications in endocrinology.
    Vogeser M; Parhofer KG
    Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):559-70. PubMed ID: 17943689
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LC-MS/MS method development and validation for the determination of polymyxins and vancomycin in rat plasma.
    Cheng C; Liu S; Xiao D; Hollembaek J; Yao L; Lin J; Hansel S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(28):2831-8. PubMed ID: 20850394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.